Overview
  • Home
  • Docs
  • Pricing
Platform
  • Markets Hub
  • Stock Screener
  • Market Calendar
  • AI Chat
About
  • About
  • Contact Us
Resources
  • Blog
  • Changelog
  • Help Center
Legal
  • Terms of Service
  • Privacy Policy
  • AI Policy
Log In
© 2026 DTS Analytics LLC. All Rights Reserved.

Vantafin provides market data and research tools for informational purposes only and does not constitute investment advice. Data may be delayed, incomplete, or incorrect. You are solely responsible for your investment decisions. See our Terms of Service.

Vantafin
Pricing
Log InView plans

Blog

Market News

Timely recaps and market context, backed by filings, fundamentals, and live data.

View plans
AllMarket NewsGuides & Comparisons
Topics:
AllAnnouncementsTutorialsMarket NewsProduct UpdatesCompany ProfilesData & APIs
RITR Stock Surges 375% on Cainiao Deal, Then Drops 57%: What Happened - RITR (Market News)
Aug 5, 2026Market News
RITR-0.20(-57.26%)

RITR Stock Surges 375% on Cainiao Deal, Then Drops 57%: What Happened

Reitar Logtech (RITR) rocketed 375-450% on Aug 3 after signing a global warehousing pact with Alibaba's Cainiao, then gave back 57% on Aug 4. Here is what to know.

Tigo Energy Q2 2026 Earnings: Revenue Miss and Full-Year Guidance Slashed to $100-110M - TYGO EARNINGS (Market News)
Aug 5, 2026Market News
TYGO+0.09(+4.62%)

Tigo Energy Q2 2026 Earnings: Revenue Miss and Full-Year Guidance Slashed to $100-110M

Tigo Energy beat Q2 EPS estimates but missed revenue, prompting management to cut 2026 revenue guidance by nearly 20% due to EG4 inverter delays and soft residential solar demand.

Viasat (VSAT) Q1 FY2027 Earnings: EPS Beats, Revenue Misses as Stock Drops 8% - VSAT (Market News)
Aug 5, 2026Market News
VSAT+4.87(+5.99%)

Viasat (VSAT) Q1 FY2027 Earnings: EPS Beats, Revenue Misses as Stock Drops 8%

Viasat reported Q1 fiscal 2027 results with GAAP EPS of $0.17 beating a $0.32 loss estimate, but revenue of $1.16B missed the $1.20B consensus. VSAT fell 8.6% on August 5, 2026. Here is what drove the divergence and what it means for the satellite communications company.

ENSC Reverses Course in Premarket as Profit-Takers Step In After 37% Surge - ENSC (Market News)
Aug 5, 2026Market News
ENSC+0.10(+37.17%)

ENSC Reverses Course in Premarket as Profit-Takers Step In After 37% Surge

Ensysce Biosciences saw a 37% one-day rally on massive volume reverse sharply in premarket Aug 5, as low cash and an ongoing strategic review frame a high-risk, high-volatility setup. Here is what drove the move and what to watch.

VSee Health Faces Nasdaq Delisting After 8-K Filing, Stock Plunges 28% in Premarket - VSEE (Market News)
Aug 5, 2026Market News
VSEE-0.00(-4.55%)

VSee Health Faces Nasdaq Delisting After 8-K Filing, Stock Plunges 28% in Premarket

VSee Health (VSEE) received a Nasdaq Staff Delisting Determination on Aug 4, 2026, triggering a 28% premarket plunge. Trading suspends Aug 6. Here is what happened and what comes next.

Vivos Therapeutics Plunges 33% After Patent Grant: What Happened - VVOS (Market News)
Aug 5, 2026Market News
VVOS+0.04(+9.89%)

Vivos Therapeutics Plunges 33% After Patent Grant: What Happened

VVOS stock surged 10% on patent news Aug 4, then collapsed 33% in after-hours. Microcap dilution risks and cash burn explain the sell-the-news reversal.

SXTC Dilution Overhang Sparks Sharp Reversal After Retail-Driven Spike - SXTC (Market News)
Aug 5, 2026Market News
SXTC+0.05(+60.08%)

SXTC Dilution Overhang Sparks Sharp Reversal After Retail-Driven Spike

China SXT Pharmaceuticals surged ~60% on Aug 4 with no new catalyst, then reversed hard as dilution pressure from a $9M registered direct offering overwhelmed speculative buying.

Autonomix Surges 434% on Patent News, Drops 24% in Premarket as Traders Book Gains - AMIX (Market News)
Aug 5, 2026Market News
AMIX+15.85(+434.25%)

Autonomix Surges 434% on Patent News, Drops 24% in Premarket as Traders Book Gains

AMIX shares exploded 434% on Aug 4 after a new patent for nerve-sensing cancer tech, then reversed sharply in premarket trading. Here is what drove the move and what traders are watching next.

Jin Medical International Reports H1 FY2026: Revenue Falls 9.7%, Gross Margin Improves - ZJYL (Market News)
Aug 5, 2026Market News
ZJYL+0.01(+0.52%)

Jin Medical International Reports H1 FY2026: Revenue Falls 9.7%, Gross Margin Improves

Jin Medical International (ZJYL) reports H1 FY2026 revenue of $8.9 million, down 9.7% year-over-year, while gross margin improved to 26.9%. The stock surged 27% on the news.

…